Table 1 Summary of the matched replicated metabolites.

From: Omics data integration suggests a potential idiopathic Parkinson’s disease signature

VMH ID

Common name

# Increased

# Decreased

Inconsistent

Increased samples

Decreased samples

nrpphr

Norepinephrine

0

2

0

Plasma38,39

dopa

Dopamine

2

2

1

Plasma69; CSF70

Plasma38; Serum42

ins

Inosine

0

2

0

Plasma42; CSF43

gly

Glycine

6

0

0

Plasma38,48; Serum44; Urine45,46; Saliva47

citr_L

Citrulline

0

3

0

Serum40,41,42

gln_L

Glutamine

8

1

1

Plasma48,71,72; Serum44,73; Putamen74; CSF70; Urine75

CSF76

asp_L

Aspartic acid

3

1

1

Plasma38; Urine45; Serum77

Serum44

ile_L

Isoleucine

6

1

1

Serum73; CSF72; Fecal78; Urine45,75; Saliva47

Fecal79

met_L

Methionine

3

2

1

Plasma49,76; CSF70

Plasma49,80

ser_L

Serine

2

2

1

Plasma49; CSF76

Serum41,44

tyr_L

Tyrosine

10

3

1

Plasma39,48,81; Serum44,74,77,82; Urine45,75; Saliva47

Fecal79,83; Plasma84

val_L

Valine

2

1

1

Serum73; Saliva47

Fecal79

4abut

GABA

4

0

0

Plasma38; Urine45,46; Saliva47

cit

Citric acid

4

2

1

Plasma85; Serum73,86; CSF70

Plasma87; Serum44

crn

Carnitine

1

2

1

Plasma88

Plasma89; CSF70

  1. Metabolites identified in metabolic modeling to be changed in IPD cells and also associated with PD diagnosis in more than one clinical study. VMH ID: metabolite name in Recon 3D.